(Q40916630)

24 September 2017

1 reference

title

Factors affecting topotecan sensitivity in human leukemia samples (English)

1 reference

24 September 2017

1

1 reference

24 September 2017

Gore SD

2

1 reference

24 September 2017

Letendre L

3

1 reference

24 September 2017

Svingen PA

4

1 reference

24 September 2017

Kottke T

5

1 reference

24 September 2017

Buckwalter CA

6

1 reference

24 September 2017

Jones RJ

7

1 reference

24 September 2017

Grochow LB

8

1 reference

24 September 2017

Burke PJ

9

1 reference

24 September 2017

Donehower RC

10

1 reference

24 September 2017

Rowinsky EK

11

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

Annals of the New York Academy of Sciences

24 September 2017

published in

1 reference

24 September 2017

volume

803

1 reference

24 September 2017

page(s)

128-142

1 reference

Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26382.X

Increment of DNA topoisomerases in chemically and virally transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26382.X

Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26382.X

SV40 DNA replication intermediates: analysis of drugs which target mammalian DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26382.X

Topoisomerase poisons: harnessing the dark side of enzyme mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26382.X

In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26382.X

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26382.X

Effect of v-rasH on sensitivity of NCI-H82 human small cell lung cancer cells to cisplatin, etoposide, and camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26382.X

10.1111/J.1749-6632.1996.TB26382.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference